pathogenesis of cardiac remodeling [7, 8] . The putative loss 2 . Adrenomedullin: an endogenous anti-remodeling of balance of multiple positive and negative effects of factor? these cytokine / growth factors in post-MI heart is of particular interest. The majority of well-characterized Elevated cardiac biomechanical stress is a likely 'masmediators of phenotypic end-points are trophic and associter-switch' that contributes to the release of an array of ated with maladaptive remodeling in the post-MI heart. For biochemical signals and secondary ventricular remodeling example, angiotensin II is an important stimulator of cell [16] . Data presented in this issue indicate that in rats proliferation and extracellular matrix protein synthesis infused with recombinant human AM for 4 weeks were while TGF-b is a potent mediator of extracellular matrix characterized by significantly reduced heart left ventricular protein synthesis and cardiac fibroblast phenotype. In end-diastolic pressure, LV weight / body weight ratio, primary cardiac fibroblasts, angiotensin II may mediate the myocyte cross-sectional area, and collagen volume fraction rapid phosphorylation and nuclear translocation of R-Smad (as determined by Sirius Red staining of LV segments) proteins, which are classically phosphorylated by the when compared to the saline-infused MI groups. AM has kinase motif on the TbRI receptor [9] . CT-1 has been attracted the attention of clinicians and basic scientists as shown to be elevated in the serum of patients with various its baseline plasma levels are significantly elevated in cardiac diseases including unstable angina pectoris [10] , patients with overt heart failure versus levels in healthy myocardial infarction [11] , and heart failure [12] . CT-1 patients [17, 18] . Recent work addressing the regional and induces cardiomyocyte hypertrophy [8] and cardiac fisystemic effects of exogenous AM provided data indicatbroblast proliferation [13] . Angiotensin II is known to ing significant reductions in mean arterial pressure and increase CT-1 expression in fibroblasts [14] . Thus it could peripheral resistance but increased heart rate and cardiac be argued that this subset of trophic factors function in a index [19] . Further, AM is known to be up-regulated both coordinated manner via a significant modicum of postin plasma of exercised patients [20] and in brain tissues receptor cross-talk. If the fate of cardiac myocytes is following repeated bouts of hypoxia and reoxygenation; in considered, this group of trophic factors tend to share the the latter, AM may be an important contributor to hypoxic same end-point; i.e., eventual maladaptive cardiac hypreconditioning in mammalian tissue [21] . How does AM pertrophy typified by cardiac myocyte growth and expanmanage to exert these effects? A recent study of exsion of the cardiac interstitium. While much of the thinking perimental malignant hypertension provides evidence that behind current therapeutic approaches to treat post-MI chronic adrenomedullin infusion is renoprotective and may heart failure deals with abrogation of specific trophic also inhibit the circulating and intrarenal renin-angiotensin pathways, implementation of naturally occurring factors system [22] . Others have reported that AM may inhibit that a priori delay the onset or otherwise ameliorate cardiac ischemia-reperfusion injury via its NO-releasing activity remodeling are now being pursued. What of novel factors [23] . Further, adrenomedullin's effects may be potentiated that may exert inhibitory effects on growth or proliferation by modification of adrenomedullin receptors in heart with regard to cardiac myocytes and myofibroblast proliffailure insofar as in failing, pressure-overloaded hearts, eration? Is their role important to the onset and severity of adrenomedullin receptor activity-modifying protein 3 cardiac remodeling, and thus to the pathogenesis of post-(RAMP3) is upregulated versus expression in controls MI heart failure? Finally, is the presence of anti-trophic [24] . Adrenomedullin's role in counteracting cardiovascufactors significant in the post-MI heart insofar as they may lar damage associated with angiotensin II and salt loading mediate so-called adaptive changes and thus provide a was recently addressed [25] . In studies using heterozygous balancing influence to the effects of trophic factors?
AM knock-out mice (1 / 2) that express |50% of plasma In the current issue of Cardiovascular Research, Nakaand organ AM of wild-type animals (1 / 1) significantly mura et al. investigate the general premise that long-term greater myocardial damage was noted versus AM (1 / 1) administration of human adrenomedullin (AM) to rats with animals in the presence of high levels of exogenous large myocardial infarction is attended by the cardioangiotensin II and salt [25] . Damage to hearts in this study protective effects including attenuation of left ventricular was gauged via coronary artery perivascular fibrosis and remodeling, as well as normalizing effects on cardiac intimal hyperplasia. Burnett and co-workers [26] have hemodynamics and endogenous hormonal flux in exprovided a further connection of AM activation and perimental hearts [15] . Their general hypothesis examined angiotensin II in experimental pacing-induced failure is that AM acts locally or systemically to halt the prowherein they have observed attenuated AM release in the gression of left ventricular remodeling in post-MI rat heart. presence of chronic ACE inhibition. Work carried out by The data presented provides a significant extension of the Tsuruda et al. [27] , as well as Tomoda et al. [28] , indicate literature and provides a catalogue of beneficial effects of that AM is synthesized and released from cardiac chronic infusion of AM in post-MI heart failure. The myocytes and fibroblasts. The relatively early prediction progressive changes that normally occur in cardiac phenoby Horio et al. [29] that AM may function to suppress type and function are significantly altered.
cardiac fibrosis in cardiac remodeling is borne out by the protective treatment modality in myocardial infarction.
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